<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="353">
  <stage>Registered</stage>
  <submitdate>1/09/2005</submitdate>
  <approvaldate>6/09/2005</approvaldate>
  <actrnumber>ACTRN12605000322639</actrnumber>
  <trial_identification>
    <studytitle>An Open Label Study of the use of Aripiprazole in the Treatment of Chronic Post Traumatic Stress Disorder</studytitle>
    <scientifictitle>A pilot Open Label Study of Aripiprazole as Add On Therapy in Post Traumatic Stress disorder as measured by impact on CAPS-2 scores</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Post Traumatic stress Disorder</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Other mental health disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>8 week Open label prescription of Aripiprazole, in addition to any current anti-depressant therapy.</interventions>
    <comparator>No comparator - open label study</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in CAPS2 score from baseline over 8 weeks treatment</outcome>
      <timepoint>At the end of the study.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in HAM-D, CGI, PCL, AUDIT and DAR scores over same time period.</outcome>
      <timepoint>At the end of the study.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>PTSD according to DSM-IV criteria and a baseline CAPS 2 score greater than 50. </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Current substance use disorder.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>9/03/2006</anticipatedstartdate>
    <actualstartdate>9/03/2006</actualstartdate>
    <anticipatedenddate />
    <actualenddate>30/03/2007</actualenddate>
    <samplesize>20</samplesize>
    <actualsamplesize>20</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Austin Health - Heidelberg Repatriation Hospital - Heidelberg West</hospital>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Austin Health</primarysponsorname>
    <primarysponsoraddress>145 Studley Road
Heidelberg, Vic 3084</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Bristol Myers Squibb Pharmaceuticals</fundingname>
      <fundingaddress>556 Princess Highway
Noble Park Vic 3174</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This clinical research study was completed in 2009.</summary>
    <trialwebsite />
    <publication>None</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Austin Hospital HREC</ethicname>
      <ethicaddress>145 Studley Rd, Heidelberg Vic 3081</ethicaddress>
      <ethicapprovaldate>2/02/2006</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Ms</title>
      <name>Iveta Krivonos</name>
      <address>Department of Psychiatry
Heidelberg Repatriation Hospital
Banksia St
Heidleberg West  VIC 3081</address>
      <phone>+61 3 94964339</phone>
      <fax>+61 3 94962360</fax>
      <email>iveta.krivonos@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Associate Professor Malcolm Hopwoood</name>
      <address>Department of Psychiatry
Heidelberg Repatriation Hospital
Banksia St
Heidleberg West VIC 3081</address>
      <phone>+61 3 94962360</phone>
      <fax>+61 3 94962360</fax>
      <email>malcolm.hopwood@austin.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Malcolm Hopwood</name>
      <address>145 Studley Road
Heidelberg Vic 3084</address>
      <phone>+61 3 9496 2750</phone>
      <fax />
      <email>mhopwood@austin.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>